Evidence map›Paper›PMID 25628843›Full record

ArticleIranian journal of cancer prevention2014

Efficient lentiviral transduction of adipose tissue-derived mouse mesenchymal stem cells and assessment of their penetration in female mice cervical tumor model.

Azra Kenarkoohi, Masoud Soleimani, Taravat Bamdad, Hoorieh Soleimanjahi, Hajar Estiri, Mohammad Hadi Razavi-Nikoo

Abstract read
In one paragraph

Article in Iranian journal of cancer prevention, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. HSV-TK Expressing Mesenchymal Stem Cells Exert Inhibitory Effect on Cervical Cancer Model.International journal of molecular and cellular medicine · 2020
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Azra KenarkoohiDept. of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Masoud SoleimaniDept. of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Taravat BamdadDept. of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Hoorieh SoleimanjahiDept. of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Hajar EstiriDept. of Molecular Biology and Genetic Engineering, Stem Cell Technology Research Center, Tehran, Iran.
Mohammad Hadi Razavi-NikooDept. of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough the incidence of cervical cancer has reduced during last years, but it causes mortality among women. Many efforts have performed to develop new drugs and strategy for treatment of cervical cancer. Adipose Tissue-Derived mouse Mesenchymal Stem Cells (MSCs) has many advantages which make them a suitable choice as a cell therapeutic agent in cancer treatment. In this study, we aimed to develop an improved protocol for Mouse MSCs transduction as well as assess the homing capacity and incorporation of MSCs in cervical cancer model.

methodsMScs were isolated from the mouse adipose tissue and characterized by differentiation and flow cytometry. In our study, lentiviral vector transductions of MSCs performed. Their penetrations were detected in tissue sections after injection of transduced MSCs to female C57BL/6 mice as a cervical cancer model.

resultsResults showed that MSCs were efficiently transduced with lentiviral vector resulting in efficient tumor penetration.

conclusionThe results provide evidence that MSCs were able to penetrate into the tumor mass of cervical tumor model and are good vehicles for gene transfer to cervical cancer.

Indexed as

Adipose Tissue-Derived mouse Mesenchymal Stem Cellscervical cancerLentivectorTransduction

Identifiers

PMID25628843
PMCPMC4307105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.